A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Lots of V114 in Healthy Infants (V114-008)
Clinical trial NCT02987972 · COMPLETED
Trial details
- NCT number
- NCT02987972
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-21
- Primary completion
- 2018-10-04
- Enrollment
- 1051
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.